RxDoctor Payments Data

Christopher Carpenter, MD

Family Medicine · Castle Rock, CONPI 1508846023

Payments from drug & device makers

$1,501in general payments, 2019–2025

Across 78 payments — averaging $19.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$396
  • Novo Nordisk$195
  • AbbVie$158
  • Lilly USA, LLC$104
  • Astellas Pharma US Inc$81
  • Edwards Lifesciences$66
  • plus $501 from 19 others

What the payments were for

  • Food & beverage$1,501100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,501 in reported general payments places this provider in the 80th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$58,627
Medicare patients
196
Services billed
1,106

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban59$84,021
XareltoRivaroxaban45$58,648
JanumetSitagliptin Phos/Metformin Hcl38$52,686
JanuviaSitagliptin Phosphate39$50,423
OzempicSemaglutide37$49,559
JardianceEmpagliflozin23$34,939
LinzessLinaclotide28$26,284
Atorvastatin Calcium383$3,701
Levothyroxine Sodium327$3,069
Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide89$3,020
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide52$2,477
Colchicine25$1,994
Rosuvastatin Calcium131$1,920
Lantus SolostarInsulin Glargine,hum.Rec.Anlog25$1,851
Allopurinol118$1,294

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanumet, Januvia$22$103,10977 claims
PfizerEliquis, Levoxyl$52$84,84583 claims
Johnson & JohnsonXarelto$62$58,64845 claims
Novo NordiskOzempic$195$49,55937 claims
AbbVieLinzess, Synthroid$158$27,48750 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Castle Rock

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →